Aqr Capital Management LLC Ultragenyx Pharmaceutical Inc. Transaction History

Aqr Capital Management LLC

  • $75.6 Billion
  • Q4 2024

A detailed history of Aqr Capital Management LLC transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Aqr Capital Management LLC holds 280,547 shares of RARE stock, worth $11.7 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
280,547
Previous 1,044,373 73.14%
Holding current value
$11.7 Million
Previous $58 Million 79.66%
% of portfolio
0.02%
Previous 0.08%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025
SELL
$42.07 - $57.72 $32.1 Million - $44.1 Million
-763,826 Reduced 73.14%
280,547 $11.8 Million
Q3 2024

Nov 14, 2024
BUY
$40.21 - $59.36 $38.1 Million - $56.2 Million
947,273 Added 975.56%
1,044,373 $58 Million
Q2 2024

Aug 14, 2024
SELL
$37.42 - $51.61 $5.77 Million - $7.95 Million
-154,097 Reduced 61.35%
97,100 $3.99 Million
Q1 2024

May 15, 2024
BUY
$43.02 - $53.69 $3.46 Million - $4.32 Million
80,508 Added 47.17%
251,197 $11.7 Million
Q4 2023

Feb 14, 2024
BUY
$31.73 - $49.19 $5.42 Million - $8.4 Million
170,689 New
170,689 $8.16 Million
Q1 2023

May 15, 2023
BUY
$36.99 - $48.71 $739,689 - $974,053
19,997 Added 125.66%
35,911 $1.44 Million
Q4 2022

Feb 14, 2023
BUY
$33.72 - $46.33 $191,934 - $263,710
5,692 Added 55.68%
15,914 $737,000
Q3 2022

Nov 14, 2022
BUY
$39.96 - $66.14 $408,471 - $676,083
10,222 New
10,222 $423,000
Q3 2021

Nov 15, 2021
SELL
$77.92 - $102.4 $740,240 - $972,800
-9,500 Closed
0 $0
Q2 2021

Aug 16, 2021
SELL
$92.19 - $115.71 $1.78 Million - $2.23 Million
-19,284 Reduced 67.0%
9,500 $906,000
Q1 2021

May 17, 2021
SELL
$106.9 - $167.73 $987,114 - $1.55 Million
-9,234 Reduced 24.29%
28,784 $3.28 Million
Q4 2020

Feb 16, 2021
BUY
$84.4 - $177.39 $756,139 - $1.59 Million
8,959 Added 30.83%
38,018 $5.26 Million
Q3 2020

Nov 16, 2020
BUY
$72.98 - $90.0 $115,016 - $141,840
1,576 Added 5.73%
29,059 $2.39 Million
Q2 2020

Aug 17, 2020
BUY
$46.91 - $78.22 $179,946 - $300,051
3,836 Added 16.22%
27,483 $2.15 Million
Q1 2020

May 15, 2020
BUY
$33.8 - $62.9 $615,836 - $1.15 Million
18,220 Added 335.73%
23,647 $1.05 Million
Q4 2019

Feb 14, 2020
BUY
$36.08 - $45.83 $195,806 - $248,719
5,427 New
5,427 $232,000
Q3 2019

Nov 14, 2019
SELL
$42.5 - $63.11 $309,527 - $459,630
-7,283 Closed
0 $0
Q2 2019

Aug 14, 2019
BUY
$54.93 - $74.36 $400,055 - $541,563
7,283 New
7,283 $462,000
Q1 2019

May 14, 2019
SELL
$39.87 - $69.36 $313,298 - $545,030
-7,858 Closed
0 $0
Q4 2018

Feb 14, 2019
BUY
$38.89 - $77.3 $37,956 - $75,444
976 Added 14.18%
7,858 $342,000
Q3 2018

Nov 15, 2018
BUY
$71.81 - $90.15 $494,196 - $620,412
6,882 New
6,882 $525,000

Others Institutions Holding RARE

# of Institutions
344
Shares Held
86.6M
Call Options Held
675K
Put Options Held
846K
View Full List

About Ultragenyx Pharmaceutical Inc.

RARE Quotes by TradingView
  • Ticker RARE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,036,896
  • Market Cap $2.93B
  • Description
  • Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...
More about RARE
Track This Portfolio

Track Aqr Capital Management LLC Portfolio

Follow Aqr Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aqr Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email